LGALS13, also known as galectin-13, is a protein encoded by the corresponding gene. It is also commonly referred to as placental protein 13 (PP13). Galectin-13 specifically binds to β-galactosides and is involved in cell - cell and cell - matrix interactions. It participates in the TGF - β signaling pathway, which is crucial for cell growth, differentiation, and apoptosis.
Abnormal expression of LGALS13 is associated with pre - eclampsia and other pregnancy - related disorders. In drug development, targeting galectin - 13 is being explored as a potential therapeutic approach for these diseases. Research efforts aim to develop drugs that can modulate its function to improve pregnancy outcomes.
The following LGALS13 reagents supplied by CUSABIO are manufactured under a strict quality control system. Multiple applications have been validated and solid technical support is offered.
LGALS13 Proteins for Homo sapiens (Human)
Code | Product Name | Source |
---|---|---|
CSB-YP883408HU CSB-EP883408HU CSB-BP883408HU CSB-MP883408HU CSB-EP883408HU-B |
Recombinant Human Galactoside-binding soluble lectin 13 (LGALS13) | Yeast E.coli Baculovirus Mammalian cell In Vivo Biotinylation in E.coli |
LGALS13 ELISA Kit for Homo sapiens (Human)
Code | Product Name | Sample Types | Sensitivity |
---|---|---|---|
CSB-E12733h | Human placental protein 13,PP13 ELISA Kit | serum, urine, tissue homogenates | 3.9 pg/mL |